4.8 Review

Regulatory T cell-derived exosomes: possible therapeutic and diagnostic tools in transplantation

期刊

FRONTIERS IN IMMUNOLOGY
卷 5, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2014.00555

关键词

regulatory T cells; exosomes and immune modulation

资金

  1. British Heart Foundation
  2. Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Center
  3. Medical Research Council [1577072] Funding Source: researchfish

向作者/读者索取更多资源

Exosomes are extracellular vesicles released by many cells of the body. These small vesicles play an important part in intercellular communication both in the local environment and systemically, facilitating in the transfer of proteins, cytokines as well as miRNA between cells. The observation that exosomes isolated from immune cells such as dendritic cells (DCs) modulate the immune response has paved the way for these structures to be considered as potential immunotherapeutic reagents. Indeed, clinical trials using DC derived exosomes to facilitate immune responses to specific cancer antigens are now underway. Exosomes can also have a negative effect on the immune response and exosomes isolated from regulatory T cells (Tregs) and other subsets of T cells have been shown to have immune suppressive capacities. Here, we review what is currently known about Treg derived exosomes and their contribution to immune regulation, as well as highlighting their possible therapeutic potential for preventing graft rejection, and use as diagnostic tools to assess transplant outcome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress

Adam G. Laing, Giorgia Fanelli, Andrei Ramirez-Valdez, Robert I. Lechler, Giovanna Lombardi, Paul T. Sharpe

PLOS ONE (2019)

Article Immunology

Pharmacological inhibition of RORC2 enhances human Th17-Treg stability and function

Dominic A. Boardman, Rosa Garcia, Sabine M. Ivison, Brian Bressler, T. G. Murali Dhar, Qihong Zhao, Megan K. Levings

EUROPEAN JOURNAL OF IMMUNOLOGY (2020)

Article Cell Biology

Regulatory T Cell Extracellular Vesicles Modify T-Effector Cell Cytokine Production and Protect Against Human Skin Allograft Damage

Sim Lai Tung, Giorgia Fanelli, Robert Ian Matthews, Jordan Bazoer, Marilena Letizia, Gema Vizcay-Barrena, Farid N. Faruqu, Christina Philippeos, Rosalind Hannen, Khuloud T. Al-Jamal, Giovanna Lombardi, Lesley Ann Smyth

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Medicine, Research & Experimental

Rationale for targeting complement in COVID-19

Anastasia Polycarpou, Mark Howard, Conrad A. Farrar, Roseanna Greenlaw, Giorgia Fanelli, Russell Wallis, Linda S. Klavinskis, Steven Sacks

EMBO MOLECULAR MEDICINE (2020)

Article Biochemical Research Methods

A method for expansion and retroviral transduction of mouse regulatory T cells

Dan Wu, May Q. Wong, Jens Vent-Schmidt, Dominic A. Boardman, Theodore S. Steiner, Megan K. Levings

Summary: This study describes a new method for purifying, expanding, and retrovirally transducing mouse Tregs, and confirms the feasibility of the method in experiments. By using this method, it is possible to study transduced Tregs in animal models, providing a new avenue for research on genetically engineered Treg therapy for various inflammatory diseases.

JOURNAL OF IMMUNOLOGICAL METHODS (2021)

Article Immunology

Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects via Adult Progenitor Cell Co-Culture

James L. Reading, Valerie D. Roobrouck, Caroline M. Hull, Pablo Daniel Becker, Jelle Beyens, Alice Valentin-Torres, Dominic Boardman, Estefania Nova Lamperti, Samantha Stubblefield, Giovanna Lombardi, Robert Deans, Anthony E. Ting, Timothy Tree

Summary: Recent clinical experience has shown that using MAPC cell co-culture can enhance the ex vivo expansion efficiency of Treg cells, reducing manufacturing time and increasing yield. MulTreg cells are easier to expand in patients with autoimmune diseases, indicating potential clinical utility.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, Sergio Abrignani, Richard Addo, Muebeccel Akdis, Immanuel Andrae, Francesco Andreata, Francesco Annunziato, Eduardo Arranz, Petra Bacher, Sudipto Bari, Vincenzo Barnaba, Joana Barros-Martins, Dirk Baumjohann, Cristian G. Beccaria, David Bernardo, Dominic A. Boardman, Jessica Borger, Chotima Boettcher, Leonie Brockmann, Marie Burns, Dirk H. Busch, Garth Cameron, Ilenia Cammarata, Antonino Cassotta, Yinshui Chang, Fernando Gabriel Chirdo, Eleni Christakou, Luka Cicin-Sain, Laura Cook, Alexandra J. Corbett, Rebecca Cornelis, Lorenzo Cosmi, Martin S. Davey, Sara De Biasi, Gabriele De Simone, Genny del Zotto, Michael Delacher, Francesca Di Rosa, James Di Santo, Andreas Diefenbach, Jun Dong, Thomas Doerner, Regine J. Dress, Charles-Antoine Dutertre, Sidonia B. G. Eckle, Pascale Eede, Maximilien Evrard, Christine S. Falk, Markus Feuerer, Simon Fillatreau, Aida Fiz-Lopez, Marie Follo, Gemma A. Foulds, Julia Froebel, Nicola Gagliani, Giovanni Galletti, Anastasia Gangaev, Natalio Garbi, Jose Antonio Garrote, Jens Geginat, Nicholas A. Gherardin, Lara Gibellini, Florent Ginhoux, Dale I. Godfrey, Paola Gruarin, Claudia Haftmann, Leo Hansmann, Christopher M. Harpur, Adrian C. Hayday, Guido Heine, Daniela Carolina Hernandez, Martin Herrmann, Oliver Hoelsken, Qing Huang, Samuel Huber, Johanna E. Huber, Jochen Huehn, Michael Hundemer, William Y. K. Hwang, Matteo Iannacone, Sabine M. Ivison, Hans-Martin Jaeck, Peter K. Jani, Baerbel Keller, Nina Kessler, Steven Ketelaars, Laura Knop, Jasmin Knopf, Hui-Fern Koay, Katja Kobow, Katharina Kriegsmann, H. Kristyanto, Andreas Krueger, Jenny F. Kuehne, Heike Kunze-Schumacher, Pia Kvistborg, Immanuel Kwok, Daniela Latorre, Daniel Lenz, Megan K. Levings, Andreia C. Lino, Francesco Liotta, Heather M. Long, Enrico Lugli, Katherine N. MacDonald, Laura Maggi, Mala K. Maini, Florian Mair, Calin Manta, Rudolf Armin Manz, Mir-Farzin Mashreghi, Alessio Mazzoni, James McCluskey, Henrik E. Mei, Fritz Melchers, Susanne Melzer, Dirk Mielenz, Leticia Monin, Lorenzo Moretta, Gabriele Multhoff, Luis Enrique Munoz, Miguel Munoz-Ruiz, Franziska Muscate, Ambra Natalini, Katrin Neumann, Lai Guan Ng, Antonia Niedobitek, Jana Niemz, Larissa Nogueira Almeida, Samuele Notarbartolo, Lennard Ostendorf, Laura J. Pallett, Amit A. Patel, Gulce Itir Percin, Giovanna Peruzzi, Marcello Pinti, A. Graham Pockley, Katharina Pracht, Immo Prinz, Irma Pujol-Autonell, Nadia Pulvirenti, Linda Quatrini, Kylie M. Quinn, Helena Radbruch, Hefin Rhys, Maria B. Rodrigo, Chiara Romagnani, Carina Saggau, Shimon Sakaguchi, Federica Sallusto, Lieke Sanderink, Inga Sandrock, Christine Schauer, Alexander Scheffold, Hans U. Scherer, Matthias Schiemann, Frank A. Schildberg, Kilian Schober, Janina Schoen, Wolfgang Schuh, Thomas Schueler, Axel R. Schulz, Sebastian Schulz, Julia Schulze, Sonia Simonetti, Jeeshan Singh, Katarzyna M. Sitnik, Regina Stark, Sarah Starossom, Christina Stehle, Franziska Szelinski, Leonard Tan, Attila Tarnok, Julia Tornack, Timothy I. M. Tree, Jasper J. P. van Beek, Willem van de Veen, Klaas van Gisbergen, Chiara Vasco, Nikita A. Verheyden, Anouk von Borstel, Kirsten A. Ward-Hartstonge, Klaus Warnatz, Claudia Waskow, Annika Wiedemann, Anneke Wilharm, James Wing, Oliver Wirz, Jens Wittner, Jennie H. M. Yang, Juhao Yang

Summary: The third edition of Flow Cytometry Guidelines provides comprehensive information on phenotypes and functional assays of major human and murine immune cell subsets, as well as clinical sample analysis and applications in various diseases. It also includes expert tips, tricks, and pitfalls to avoid, making it an essential handbook for researchers.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Review Allergy

Emerging strategies for treating autoimmune disorders with genetically modified Treg cells

Dominic A. Boardman, Megan K. Levings

Summary: This article reviews the application of gene editing technologies in Treg cell therapy, focusing on preclinical strategies to enhance the efficacy, function, and survival of Treg cells. It explores methods for generating immunoregulatory cells ex vivo, discusses emerging strategies such as using chimeric antigen receptors for antigen specificity, and outlines concepts for repurposing conventional T cells to target and destroy autoreactive and alloreactive lymphocytes. The article also discusses the key obstacles currently limiting the clinical adoption of Treg cell therapy and proposes potential future research directions.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Cell Biology

Pluripotent Stem Cell-Derived Hepatocytes Inhibit T Cell Proliferation In Vitro through Tryptophan Starvation

Marco Romano, Raul Elgueta, Daniel McCluskey, Ana Maria Ortega-Prieto, Emilie Stolarczyk, Francesco Dazzi, Baltasar Lucendo-Villarin, Jose Meseguer-Ripolles, James Williams, Giorgia Fanelli, David C. Hay, Fiona M. Watt, Giovanna Lombardi

Summary: Regenerative medicine aims to replace damaged tissues by stimulating tissue repair or transplanting cells. Pluripotent stem cells have the potential for unlimited cell production, making them valuable for regenerative medicine. However, immune responses pose a challenge to success. This study investigates the immunological properties of human pluripotent stem cell-derived hepatocyte-like cells and shows their potential for in vitro immunoregulation.
Article Immunology

Flagellin-specific human CAR Tregs for immune regulation in IBD

Dominic A. Boardman, May Q. Wong, William D. Rees, Dan Wu, Megan E. Himmel, Paul C. Orban, Jens Vent-Schmidt, Nicholas C. Zachos, Theodore S. Steiner, Megan K. Levings

Summary: Regulatory T cell (Treg) therapy is a promising strategy for treating inflammatory bowel disease (IBD). A novel chimeric antigen receptor (CAR) specific for flagellin derived from Escherichia coli H18 (FliC) was developed to confer FliC-specificity to human Tregs. FliC-CAR Tregs showed specificity and functionality, and demonstrated potential in treating IBD by suppressing inflammation and promoting the establishment of colon-derived epithelial cell monolayers.

JOURNAL OF AUTOIMMUNITY (2023)

Editorial Material Surgery

Alleviating graft-versus-host disease by directing regulatory T cells to the gut ... It is all about location, location, location

Manjurul Haque, Dominic A. Boardman, Megan K. Levings

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Cell Biology

Soluble Collectin 11 (CL-11) Acts as an Immunosuppressive Molecule Potentially Used by Stem Cell-Derived Retinal Epithelial Cells to Modulate T Cell Response

Giorgia Fanelli, Marco Romano, Giovanna Lombardi, Steven H. Sacks

Summary: Retinal pigment epithelium (RPE) cell allotransplantation is a potential solution for retinal diseases. However, the RPE-complement system triggered by CL-11 could hinder the success of transplantation due to the inflammatory response and T cell recognition promotion. We found that CL-11 inhibited T cell proliferation by binding to T cells and downregulating CD28 expression. Additionally, soluble CL-11 secreted by stressed RPE cells may contribute to the immunosuppressive properties of RPE cells.
Article Biology

Modelling Graft-Versus-Host Disease in Mice Using Human Peripheral Blood Mononuclear Cells

Manjurul Haque, Dominic A. Boardman, Avery J. Lam, Katherine N. MacDonald, Lieke Sanderink, Qing Huang, Vivian C. W. Fung, Sabine Ivison, Majid Mojibian, Megan K. Levings

Summary: Graft-versus-host disease (GvHD) is a significant complication of allogeneic hematopoietic stem cell transplantation, and there is a need to recapitulate its effects in preclinical, in vivo systems. Humanized mouse models of GvHD are commonly used for this purpose, where mice are reconstituted with human immune cells and develop a condition known as xenoGvHD. This study provides detailed methods for inducing xenoGvHD in immunodeficient mice using human peripheral blood mononuclear cells, and also includes comprehensive instructions for T cell preparation, mouse monitoring, data collection, interpretation, and reporting. The protocol presented here aims to standardize the xenoGvHD model and facilitate comparison of data across different studies.

BIO-PROTOCOL (2022)

Article Biology

Suppression of Human Dendritic Cells by Regulatory T Cells

Qing Huang, Avery J. Lam, Dominic A. Boardman, Nicholas A. J. Dawson, Megan K. Levings

Summary: Regulatory T cells (Tregs) can suppress immune responses through various mechanisms and are used as cellular therapy to induce tolerance. This protocol describes a method to measure the suppression of CD80 and CD86 expression on dendritic cells by human Tregs, providing a way to assess their functional activity.

BIO-PROTOCOL (2021)

Review Immunology

Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity

Marco Romano, Giorgia Fanelli, Caraugh Jane Albany, Giulio Giganti, Giovanna Lombardi

FRONTIERS IN IMMUNOLOGY (2019)

暂无数据